Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells

Richard D. Kopke, Wei Liu, Ramin Gabaizadeh, Andrew Jacono, Joseph Feghali, David C. Spray, Phil Garcia, Howard M. Steinman, Bridgitte Malgrange, Robert J. Ruben, Leonard Rybak, Thomas R. Van De Water

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Hypothesis: Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system of Corti's organ and results in damage to the hair cells. Background: Cisplatin is a widely used chemotherapeutic agent with the dose-limiting side effect of ototoxicity. Evidence is accumulating that cisplatin interferes with the antioxidant defense system of Corti's organ. Methods: Organotypic explants of P-3 rat organ of Corti were the in vitro model system. Presence of intact auditory hair cells and stereocilia bundle integrity was assayed by phalloidin-FITC staining. Fluorescent dye probes detected H2O2 and intracellular thiol [e.g., glutathione (GSH)]. Spectrophotometric analysis determined antioxidant enzyme levels. Results: There was a rapid dose- dependent cisplatin cytotoxicity in the explants after 48 h of exposure. An accumulation of H2O2 and a reduction of GSH levels were observed within cisplatin-exposed hair cells. L-buthionine sulfoximine, an inhibitor of GSH formation, enhanced cisplatin ototoxicity, whereas N6-(2-phenylisopropyl) adenosine, an adenosine agonist, elevated antioxidant enzyme levels and ameliorated cisplatin toxicity. The following molecules protected hair cells from cisplatin-induced damage: GSH; glutathione diethyl ester (GSHe); ebselen (EBS); 4-methylthiobenzoic acid (MTBA); and D-methionine (D-MET). EBS, MTBA, and D-MET in vitro protection correlates with in vivo protection in rats. Conclusions: Organotypic culture of Corti's organ has been validated as a model for studying cisplatin toxicity and for screening otoprotective molecules. Some of the events that contribute to cisplatin's ability to damage auditory hair cells are generation of Res (e.g., H2O2), depletion of intracellular GSH, and interference with antioxidant enzymes within the cochlea. Agents that bolster the cochlea's antioxidant system can prevent cisplatin destruction of auditory hair cells. Identified protective agents may prove to be clinically useful in limiting or completely protecting from cisplatin ototoxicity.

Original languageEnglish (US)
Pages (from-to)559-571
Number of pages13
JournalAmerican Journal of Otology
Volume18
Issue number5
StatePublished - Sep 1997

Fingerprint

Auditory Hair Cells
Organ of Corti
Cisplatin
Antioxidants
Cochlea
Fluorescent Dyes
Methionine
Adenosine
Enzymes
Stereocilia
Buthionine Sulfoximine
Phalloidine
Protective Agents
Fluorescein-5-isothiocyanate
Sulfhydryl Compounds

Keywords

  • Antioxidant molecules
  • Auditory hair cells
  • Cisplatin
  • Corti's organ
  • Organotypic cultures

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. / Kopke, Richard D.; Liu, Wei; Gabaizadeh, Ramin; Jacono, Andrew; Feghali, Joseph; Spray, David C.; Garcia, Phil; Steinman, Howard M.; Malgrange, Bridgitte; Ruben, Robert J.; Rybak, Leonard; Van De Water, Thomas R.

In: American Journal of Otology, Vol. 18, No. 5, 09.1997, p. 559-571.

Research output: Contribution to journalArticle

Kopke, RD, Liu, W, Gabaizadeh, R, Jacono, A, Feghali, J, Spray, DC, Garcia, P, Steinman, HM, Malgrange, B, Ruben, RJ, Rybak, L & Van De Water, TR 1997, 'Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells', American Journal of Otology, vol. 18, no. 5, pp. 559-571.
Kopke, Richard D. ; Liu, Wei ; Gabaizadeh, Ramin ; Jacono, Andrew ; Feghali, Joseph ; Spray, David C. ; Garcia, Phil ; Steinman, Howard M. ; Malgrange, Bridgitte ; Ruben, Robert J. ; Rybak, Leonard ; Van De Water, Thomas R. / Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. In: American Journal of Otology. 1997 ; Vol. 18, No. 5. pp. 559-571.
@article{92d9c49a29a34fdb9aeb5479dcf43d70,
title = "Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells",
abstract = "Hypothesis: Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system of Corti's organ and results in damage to the hair cells. Background: Cisplatin is a widely used chemotherapeutic agent with the dose-limiting side effect of ototoxicity. Evidence is accumulating that cisplatin interferes with the antioxidant defense system of Corti's organ. Methods: Organotypic explants of P-3 rat organ of Corti were the in vitro model system. Presence of intact auditory hair cells and stereocilia bundle integrity was assayed by phalloidin-FITC staining. Fluorescent dye probes detected H2O2 and intracellular thiol [e.g., glutathione (GSH)]. Spectrophotometric analysis determined antioxidant enzyme levels. Results: There was a rapid dose- dependent cisplatin cytotoxicity in the explants after 48 h of exposure. An accumulation of H2O2 and a reduction of GSH levels were observed within cisplatin-exposed hair cells. L-buthionine sulfoximine, an inhibitor of GSH formation, enhanced cisplatin ototoxicity, whereas N6-(2-phenylisopropyl) adenosine, an adenosine agonist, elevated antioxidant enzyme levels and ameliorated cisplatin toxicity. The following molecules protected hair cells from cisplatin-induced damage: GSH; glutathione diethyl ester (GSHe); ebselen (EBS); 4-methylthiobenzoic acid (MTBA); and D-methionine (D-MET). EBS, MTBA, and D-MET in vitro protection correlates with in vivo protection in rats. Conclusions: Organotypic culture of Corti's organ has been validated as a model for studying cisplatin toxicity and for screening otoprotective molecules. Some of the events that contribute to cisplatin's ability to damage auditory hair cells are generation of Res (e.g., H2O2), depletion of intracellular GSH, and interference with antioxidant enzymes within the cochlea. Agents that bolster the cochlea's antioxidant system can prevent cisplatin destruction of auditory hair cells. Identified protective agents may prove to be clinically useful in limiting or completely protecting from cisplatin ototoxicity.",
keywords = "Antioxidant molecules, Auditory hair cells, Cisplatin, Corti's organ, Organotypic cultures",
author = "Kopke, {Richard D.} and Wei Liu and Ramin Gabaizadeh and Andrew Jacono and Joseph Feghali and Spray, {David C.} and Phil Garcia and Steinman, {Howard M.} and Bridgitte Malgrange and Ruben, {Robert J.} and Leonard Rybak and {Van De Water}, {Thomas R.}",
year = "1997",
month = "9",
language = "English (US)",
volume = "18",
pages = "559--571",
journal = "Otology and Neurotology",
issn = "1531-7129",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells

AU - Kopke, Richard D.

AU - Liu, Wei

AU - Gabaizadeh, Ramin

AU - Jacono, Andrew

AU - Feghali, Joseph

AU - Spray, David C.

AU - Garcia, Phil

AU - Steinman, Howard M.

AU - Malgrange, Bridgitte

AU - Ruben, Robert J.

AU - Rybak, Leonard

AU - Van De Water, Thomas R.

PY - 1997/9

Y1 - 1997/9

N2 - Hypothesis: Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system of Corti's organ and results in damage to the hair cells. Background: Cisplatin is a widely used chemotherapeutic agent with the dose-limiting side effect of ototoxicity. Evidence is accumulating that cisplatin interferes with the antioxidant defense system of Corti's organ. Methods: Organotypic explants of P-3 rat organ of Corti were the in vitro model system. Presence of intact auditory hair cells and stereocilia bundle integrity was assayed by phalloidin-FITC staining. Fluorescent dye probes detected H2O2 and intracellular thiol [e.g., glutathione (GSH)]. Spectrophotometric analysis determined antioxidant enzyme levels. Results: There was a rapid dose- dependent cisplatin cytotoxicity in the explants after 48 h of exposure. An accumulation of H2O2 and a reduction of GSH levels were observed within cisplatin-exposed hair cells. L-buthionine sulfoximine, an inhibitor of GSH formation, enhanced cisplatin ototoxicity, whereas N6-(2-phenylisopropyl) adenosine, an adenosine agonist, elevated antioxidant enzyme levels and ameliorated cisplatin toxicity. The following molecules protected hair cells from cisplatin-induced damage: GSH; glutathione diethyl ester (GSHe); ebselen (EBS); 4-methylthiobenzoic acid (MTBA); and D-methionine (D-MET). EBS, MTBA, and D-MET in vitro protection correlates with in vivo protection in rats. Conclusions: Organotypic culture of Corti's organ has been validated as a model for studying cisplatin toxicity and for screening otoprotective molecules. Some of the events that contribute to cisplatin's ability to damage auditory hair cells are generation of Res (e.g., H2O2), depletion of intracellular GSH, and interference with antioxidant enzymes within the cochlea. Agents that bolster the cochlea's antioxidant system can prevent cisplatin destruction of auditory hair cells. Identified protective agents may prove to be clinically useful in limiting or completely protecting from cisplatin ototoxicity.

AB - Hypothesis: Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system of Corti's organ and results in damage to the hair cells. Background: Cisplatin is a widely used chemotherapeutic agent with the dose-limiting side effect of ototoxicity. Evidence is accumulating that cisplatin interferes with the antioxidant defense system of Corti's organ. Methods: Organotypic explants of P-3 rat organ of Corti were the in vitro model system. Presence of intact auditory hair cells and stereocilia bundle integrity was assayed by phalloidin-FITC staining. Fluorescent dye probes detected H2O2 and intracellular thiol [e.g., glutathione (GSH)]. Spectrophotometric analysis determined antioxidant enzyme levels. Results: There was a rapid dose- dependent cisplatin cytotoxicity in the explants after 48 h of exposure. An accumulation of H2O2 and a reduction of GSH levels were observed within cisplatin-exposed hair cells. L-buthionine sulfoximine, an inhibitor of GSH formation, enhanced cisplatin ototoxicity, whereas N6-(2-phenylisopropyl) adenosine, an adenosine agonist, elevated antioxidant enzyme levels and ameliorated cisplatin toxicity. The following molecules protected hair cells from cisplatin-induced damage: GSH; glutathione diethyl ester (GSHe); ebselen (EBS); 4-methylthiobenzoic acid (MTBA); and D-methionine (D-MET). EBS, MTBA, and D-MET in vitro protection correlates with in vivo protection in rats. Conclusions: Organotypic culture of Corti's organ has been validated as a model for studying cisplatin toxicity and for screening otoprotective molecules. Some of the events that contribute to cisplatin's ability to damage auditory hair cells are generation of Res (e.g., H2O2), depletion of intracellular GSH, and interference with antioxidant enzymes within the cochlea. Agents that bolster the cochlea's antioxidant system can prevent cisplatin destruction of auditory hair cells. Identified protective agents may prove to be clinically useful in limiting or completely protecting from cisplatin ototoxicity.

KW - Antioxidant molecules

KW - Auditory hair cells

KW - Cisplatin

KW - Corti's organ

KW - Organotypic cultures

UR - http://www.scopus.com/inward/record.url?scp=12644293785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644293785&partnerID=8YFLogxK

M3 - Article

C2 - 9303151

AN - SCOPUS:12644293785

VL - 18

SP - 559

EP - 571

JO - Otology and Neurotology

JF - Otology and Neurotology

SN - 1531-7129

IS - 5

ER -